CAS RN: 50-35-1 | Product Number: T2524
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
|Appearance||White to Almost white powder to crystal|
|Purity(HPLC)||min. 98.0 area%|
|Purity(with Total Nitrogen)||min. 98.0 %|
|Melting Point||276 °C|
|Maximum Absorption Wavelength||300 nm|
|Solubility in water||Insoluble|
|Degree of solubility in water||60 mg/l 25 °C|
|Solubility (very soluble in)||Dimethylformamide,Dioxane|
|Solubility (very slightly)||Methanol,Acetone,Ethanol|
|Solubility (insoluble in)||Benzene,Ether,Chloroform|
|Hazard Statements||H301 : Toxic if swallowed.
H312 : Harmful in contact with skin.
H361 : Suspected of damaging fertility or the unborn child.
|Precautionary Statements||P201 : Obtain special instructions before use.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth.
P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/doctor if you feel unwell.
- Thalidomide selectively inhibits tumor necrosis factor α (TNF-α) production by stimulated human monocytes
- Thalidomide is an inhibitor of angiogenesis
- Antitumor activity of thalidomide in refractory multiple myeloma
- Timeline: The evolution of thalidomide and its IMiD derivatives as anticancer agents (a review)
- Multiple Myeloma (a review)
Safety Data Sheet (SDS) Search
The requested SDS is not available.
Please check that the Product Number you have entered is correct.
If your information is correct and you are still not able to view the requested SDS, please Contact Us for more information.